HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qing Rao Selected Research

calothrixin B

5/2021L20, a Calothrixin B analog, induces intrinsic apoptosis on HEL cells through ROS/γ-H2AX/p38 MAPK pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qing Rao Research Topics

Disease

43Leukemia
03/2022 - 06/2002
18Neoplasms (Cancer)
03/2022 - 07/2003
17Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2022 - 02/2003
5Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
03/2022 - 12/2011
4Hematologic Neoplasms (Hematological Malignancy)
01/2020 - 02/2003
3Residual Neoplasm
03/2022 - 12/2011
3Acute Promyelocytic Leukemia
12/2021 - 06/2012
3Myeloid Leukemia (Leukemia, Myelocytic)
08/2015 - 01/2004
2Infections
12/2021 - 12/2015
2Genomic Instability
12/2021 - 06/2019
2Acute Erythroblastic Leukemia (Erythroleukemia)
05/2021 - 01/2021
2Breast Neoplasms (Breast Cancer)
01/2021 - 08/2012
2Lymphoid Leukemia
01/2019 - 09/2005
2Wilms Tumor (Wilm's Tumor)
09/2017 - 12/2014
2Lymphoma (Lymphomas)
09/2005 - 09/2003
1Bacterial Infections (Bacterial Infection)
01/2022
1Cardiovascular Diseases (Cardiovascular Disease)
01/2022
1Enterovirus Infections
12/2021
1Dengue (Dengue Fever)
01/2021
1Neoplasm Metastasis (Metastasis)
01/2021
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2021
1Mitochondrial Diseases (Mitochondrial Disease)
01/2020
1B-Cell Leukemia (Leukemia, B Cell)
01/2019
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2019
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2019
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2019
1Inflammation (Inflammations)
01/2019
1Iron Deficiencies
11/2015
1Soft Tissue Infections
01/2015
1Pneumonia (Pneumonitis)
01/2015
1Bacteremia
01/2015

Drug/Important Bio-Agent (IBA)

10Chimeric Antigen ReceptorsIBA
03/2022 - 03/2016
8Proteins (Proteins, Gene)FDA Link
11/2021 - 02/2003
7Biological ProductsIBA
01/2021 - 02/2010
4Etoposide (VP 16)FDA LinkGeneric
08/2012 - 10/2008
4Messenger RNA (mRNA)IBA
02/2012 - 02/2003
3CytokinesIBA
01/2022 - 01/2019
3Cadherins (E-Cadherin)IBA
05/2014 - 09/2008
3Interleukin-18 (Interleukin 18)IBA
01/2004 - 02/2003
2SesquiterpenesIBA
01/2022 - 07/2021
2Interleukin-10 (Interleukin 10)IBA
01/2022 - 01/2021
2Therapeutic UsesIBA
08/2021 - 01/2019
2Tyrosine Kinase InhibitorsIBA
08/2021 - 08/2005
2Interleukin-2 (IL2)IBA
01/2021 - 03/2016
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 09/2015
2Daunorubicin (Cerubidine)FDA LinkGeneric
01/2020 - 09/2009
2AntigensIBA
01/2019 - 03/2016
2LigandsIBA
01/2018 - 09/2003
2Histone Deacetylase InhibitorsIBA
01/2018 - 05/2006
2GTP Phosphohydrolases (GTPases)IBA
01/2016 - 10/2013
2Imatinib Mesylate (Gleevec)FDA Link
04/2014 - 08/2005
2OligonucleotidesIBA
02/2011 - 02/2010
2Small Interfering RNA (siRNA)IBA
09/2009 - 09/2009
2Matrix Metalloproteinases (MMPs)IBA
01/2004 - 02/2003
2Macrophage Colony-Stimulating FactorIBA
07/2003 - 06/2002
1DNA (Deoxyribonucleic Acid)IBA
01/2022
1Biomarkers (Surrogate Marker)IBA
12/2021
1Inactivated VaccinesIBA
12/2021
1germacranolideIBA
07/2021
1calothrixin BIBA
05/2021
1Incaspitolide AIBA
01/2021
1Interferon-gamma (Interferon, gamma)IBA
01/2021
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2021
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
01/2021
1Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
01/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021
1Interleukin-10 ReceptorsIBA
01/2021
1Paris saponin VIIIBA
01/2021
1VaccinesIBA
01/2021
1Glutathione PeroxidaseIBA
06/2019
1Reactive Oxygen Species (Oxygen Radicals)IBA
06/2019
1compound 21IBA
04/2019
1GlycosidesIBA
04/2019
1Rituximab (Mabthera)FDA Link
01/2019
1Transcription Factors (Transcription Factor)IBA
01/2019
1Monoclonal AntibodiesIBA
01/2019
1Serine Proteases (Serine Protease)IBA
09/2017
1Prednisone (Sone)FDA LinkGeneric
08/2017
1Lysine (L-Lysine)FDA Link
05/2017
1Single-Chain AntibodiesIBA
03/2016
1IronIBA
11/2015
1Bendamustine HydrochlorideFDA Link
08/2015
1Caspase 3 (Caspase-3)IBA
08/2015
1NL-101IBA
08/2015
1Panton-Valentine leukocidinIBA
01/2015
1Staphylococcal Protein A (Protein A)IBA
01/2015
1CateninsIBA
12/2014
1RetinoidsIBA
08/2014
1AcidsIBA
08/2014
1Indicators and Reagents (Reagents)IBA
10/2013
1SurvivinIBA
10/2013
1icaritinIBA
05/2013
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
06/2012
1Metformin (Glucophage)FDA LinkGeneric
06/2012

Therapy/Procedure

10Therapeutics
03/2022 - 09/2005
5Drug Therapy (Chemotherapy)
01/2020 - 10/2011
2Immunotherapy
03/2022 - 01/2019
2Transplantation
11/2018 - 05/2014
1Traditional Medicine (Folk Remedies)
01/2022
1Intravenous Administration
05/2017